Clinical Trial Update: Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combination of sitafloxacin and ertapenem for acute pyelonephritis caused by Escherichia coli is described.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Escherichia Coli Infections
• Pyelonephritis

Drugs mentioned

• ERTAPENEM (ertapenem)
• Sitafloxacin (sitafloxacin)

Snippet

Sponsor: Mahidol University | Conditions: Infection Due to Escherichia Coli, Acute Pyelonephritis | Phase 2 | Status: UNKNOWN